| |
| |
|
| Insider
Information: |
Schuth Alexander O. |
| Relationship: |
COFO and Secretary |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
187,341 |
|
|
Indirect Shares
|
523,749 |
|
|
| Direct
Value |
$3,883,579 |
|
|
|
Indirect Value
|
$10,857,317 |
|
|
| Total
Shares |
711,090 |
|
|
| Total
Value |
$14,740,896 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -30.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-02-14 |
187,341 |
2024-02-14 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-07-06 |
4 |
AS |
$76.20 |
$762,040 |
I/I |
(10,000) |
491,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-09 |
4 |
S |
$74.66 |
$109,809 |
I/I |
(1,468) |
537,344 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-11 |
4 |
S |
$70.17 |
$214,341 |
I/I |
(3,047) |
541,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-02-04 |
4 |
AS |
$66.65 |
$678,361 |
I/I |
(10,000) |
534,562 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-01-04 |
4 |
AS |
$65.17 |
$5,246,408 |
I/I |
(70,000) |
544,562 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-06-04 |
4 |
AS |
$64.35 |
$645,500 |
I/I |
(10,000) |
501,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-03-04 |
4 |
AS |
$60.89 |
$610,171 |
I/I |
(10,000) |
531,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-05-04 |
4 |
AS |
$55.09 |
$554,864 |
I/I |
(10,000) |
511,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-09-07 |
4 |
AS |
$54.70 |
$555,485 |
I/I |
(10,000) |
474,038 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-11-04 |
4 |
AS |
$52.65 |
$528,404 |
I/I |
(10,000) |
463,083 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-08-04 |
4 |
AS |
$51.52 |
$522,233 |
I/I |
(10,000) |
481,582 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-10-04 |
4 |
AS |
$50.24 |
$505,605 |
I/I |
(10,000) |
473,083 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-08-19 |
4 |
S |
$49.56 |
$126,186 |
I/I |
(2,544) |
484,038 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-01-05 |
4 |
S |
$44.77 |
$127,415 |
I/I |
(2,846) |
457,737 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2021-12-06 |
4 |
AS |
$41.82 |
$422,736 |
I/I |
(10,000) |
453,083 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-02-09 |
4 |
S |
$37.10 |
$52,800 |
I/I |
(1,423) |
460,564 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2022-02-11 |
4 |
S |
$34.68 |
$97,208 |
I/I |
(2,803) |
465,047 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2022-08-19 |
4 |
S |
$33.22 |
$85,575 |
I/I |
(2,576) |
467,471 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COO and Secretary |
• – – |
2020-08-21 |
4 |
D |
$32.88 |
$64,248 |
I/I |
(1,954) |
614,562 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-08 |
4 |
S |
$30.89 |
$46,984 |
I/I |
(1,521) |
499,902 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-02-13 |
4 |
S |
$30.09 |
$105,225 |
I/I |
(3,497) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-07-18 |
4 |
AS |
$30.01 |
$291,157 |
I/I |
(9,702) |
518,989 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-07-17 |
4 |
AS |
$29.60 |
$296,000 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-17 |
4 |
AS |
$29.53 |
$295,339 |
I/I |
(10,000) |
497,173 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
• – – |
2023-01-04 |
4/A |
S |
$28.70 |
$83,574 |
I/I |
(2,912) |
492,309 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
